Beth McGinn
,


Durhane Wong-Rieger
,


Melissa Hogan
,


Andrew Milmore
,


Conversations

On 10/17, PhRMA will host a Twitter chat session around the subject of medicines in development for rare diseases. What are the shared priorities and interests of the diverse rare disease community that should be discussed in the Tweetchat?

Contributors Respond

Cathy Collet
,


Sharon F. Terry
,


Ryan M. Hohman, JD
,


Sascha Haverfield, Ph.D.
,


Rebecca D. Kush, Ph.D.
,


Pages

Subscribe to PhRMA RSS